This site is intended for Healthcare professionals only.

Dr Reddy’s launches generic epilepsy drug in US


Dr Reddy’s launches generic epilepsy drug in US

New Delhi: Dr Reddy’s Laboratories said it has launched Levetiracetram in Sodium Chloride injection, an anti-epileptic drug, in the US market.

The Hyderabad-based company’s drug is the generic version of HQ Specialty Pharma Corporation’s product, Dr Reddy’s Laboratories said in a statement.

According to IMS Health data, Levetiracetam in Sodium Chloride injection brand and generics had sales of around USD 37 million in the US market.



Source: PTI
0 comment(s) on Dr Reddy’s launches generic epilepsy drug in US

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted